Cyclacel Pharmaceuticals Inc (CYCC)

Cyclacel Pharma Shares Rise 11% After European Patent Allowance Notice for Plogosertib - MarketWatch

MarketWatch

Cyclacel Announces Notice of Intention to Grant New European Patent Covering Plogosertib Pharmaceutical ... - StockTitan

StockTitan

Kernel Group Holdings amends Business Combination Agreement with AIRO Group By Investing.com - Investing.com

Investing.com

Cyclacel Pharmaceuticals expands equity incentive plan - Investing.com India

Investing.com India

Cyclacel Pharmaceuticals expands equity incentive plan By Investing.com - Investing.com

Investing.com

Cyclacel Pharmaceuticals Announces Key Corporate Decisions at 2024 Annual Meeting - TipRanks.com - TipRanks

TipRanks

Analytical Lens: Exploring Cyclacel Pharmaceuticals Inc (CYCC)'s Financial Story Through Ratios – DWinneX - The Dwinnex

The Dwinnex

Analytical Lens: Exploring Cyclacel Pharmaceuticals Inc (CYCC)'s Financial Story Through Ratios – DWinneX - The Dwinnex

The Dwinnex

Oppenheimer gives an Outperform recommendation for Cyclacel Pharmaceuticals Inc (CYCC) – Knox Daily - Knox Daily

Knox Daily

$8 Million Private Placement Announcement Sends Biotech Flying - The Globe and Mail

The Globe and Mail

$8 Million Private Placement Announcement Sends Biotech Flying - The Globe and Mail

The Globe and Mail

Cushing's Syndrome Market Is Expected to Rise at a Significant CAGR During the Forecast Period | Corcept ... - Barchart

Barchart

Cyclacel Pharmaceuticals (NASDAQ:CYCC) Upgraded by StockNews.com to “Hold” - Defense World

Defense World

PepGen elevates two to executive roles By Investing.com - Investing.com Australia

Investing.com Australia

(CYCCP) Investment Report - Stock Traders Daily

Stock Traders Daily

All You Need to Know About Cyclacel Pharmaceuticals (CYCC) Rating Upgrade to Buy - MSN

MSN

Cyclacel Pharmaceuticals, Inc. (CYCC) Upgraded to Strong Buy: Here's Why - Yahoo News Malaysia

Yahoo News Malaysia

All You Need to Know About Cyclacel Pharmaceuticals (CYCC) Rating Upgrade to Buy - Yahoo Finance

Yahoo Finance

All You Need to Know About Cyclacel Pharmaceuticals (CYCC) Rating Upgrade to Buy - Zacks Investment Research

Zacks Investment Research

All You Need to Know About Cyclacel Pharmaceuticals (CYCC) Rating Upgrade to Buy - Yahoo Finance

Yahoo Finance

Knightscope gets extension to meet Nasdaq compliance By Investing.com - Investing.com

Investing.com

Cyclacel's Fadraciclib Demonstrates Efficacy in Patient-Derived Colorectal Cancer Models at the 2024 ASCO Annual ... - Morningstar

Morningstar

Cyclacel Pharmaceuticals Reports New Clinical Data at 2024 ASCO Annual Meeting Highlighting Oral Fadraciclib's ... - Morningstar

Morningstar

Cyclacel Pharmaceuticals Inc (CYCC) Stock: Uncovering 52-Week Market Trends - The InvestChronicle

The InvestChronicle

Cyclacel Pharmaceuticals Reports New Clinical Data at 2024 ASCO Annual Meeting Highlighting Oral Fadraciclib's ... - Morningstar

Morningstar

Market Highlights: Cyclacel Pharmaceuticals Inc (CYCC) Ends on a Low Note at 2.02 – DWinneX - The Dwinnex

The Dwinnex

CYCC - Cyclacel Announces Reverse Stock Split - br.ADVFN.com

br.ADVFN.com

Cyclacel Pharmaceuticals (NASDAQ:CYCC) Coverage Initiated by Analysts at StockNews.com - Defense World

Defense World

$8 Million Private Placement Announcement Sends Biotech Flying - MSN

MSN

Cyclacel Pharmaceuticals (NASDAQ:CYCC) Research Coverage Started at StockNews.com - Defense World

Defense World

(CYCCP) Technical Pivots with Risk Controls - Stock Traders Daily

Stock Traders Daily

Company News for April 11, 2017 - Yahoo New Zealand News

Yahoo New Zealand News

Principal Real Estate Income Fund, Cyclacel Pharmaceuticals, Another 6 Companies Have A High Estimated Dividend ... - Via News Agency

Via News Agency

Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) Q1 2024 Earnings Call Transcript - Insider Monkey

Insider Monkey

Earnings call: Cyclacel Pharmaceuticals reports Q1 2024 results - Investing.com ZA - Investing.com South Africa

Investing.com South Africa

Earnings call: Cyclacel Pharmaceuticals reports Q1 2024 results - Investing.com India

Investing.com India

Earnings call: Cyclacel Pharmaceuticals reports Q1 2024 results By Investing.com - Investing.com UK

Investing.com UK

Earnings call: Cyclacel Pharmaceuticals reports Q1 2024 results By Investing.com - Investing.com

Investing.com

Earnings call: Cyclacel Pharmaceuticals reports Q1 2024 results - Investing.com India

Investing.com India

Earnings call: Cyclacel Pharmaceuticals reports Q1 2024 results By Investing.com - Investing.com

Investing.com

Cyclacel Pharmaceuticals, Inc. (CYCC) Q1 2024 Earnings Call Transcript - Seeking Alpha

Seeking Alpha

Why JanOne Shares Are Trading Higher By 19%; Here Are 20 Stocks Moving Premarket - JanOne (NASDAQ:JAN) - Benzinga

Benzinga

Cyclacel Pharmaceuticals (CYCC) Set to Announce Quarterly Earnings on Tuesday - Defense World

Defense World

Oppenheimer gives an Outperform recommendation for Cyclacel Pharmaceuticals Inc (CYCC) – Knox Daily - Knox Daily

Knox Daily

Cyclacel Pharmaceuticals to Release First Quarter 2024 Financial Results

GlobeNewswire Inc.

Cyclacel Pharmaceuticals to Release First Quarter 2024 Financial Results - Morningstar

Morningstar

Cyclacel Pharmaceuticals (NASDAQ:CYCC) Price Target Lowered to $11.00 at Roth Mkm - Defense World

Defense World

Cyclacel Pharmaceuticals Announces Closing of $8.0 Million Private Placement Priced At-The-Market Under NASDAQ Rules

GlobeNewswire Inc.

Cyclacel Pharmaceuticals Announces Closing of $8.0 Million Private Placement Priced At-The-Market Under NASDAQ ... - Morningstar

Morningstar

Cyclacel Pharmaceuticals (NASDAQ: CYCC) Sees Significant Stock Volatility Amid New Financing Deal - BP Journal

BP Journal